-
Metronidazole: OAT3 Assay Workflows and Optimization
2026-08-14
Metronidazole supports two complementary research applications: mechanistic inhibition of human OAT3 and experimental targeting of anaerobic bacteria and protozoa. This workflow-focused guide explains concentration design, controls, preparation, and troubleshooting for more reproducible transporter, drug-drug interaction, and antimicrobial assays.
-
Cy3 Rabbit Anti-Goat IgG (H+L) Antibody Guide
2026-08-13
Cy3 Rabbit Anti-Goat IgG (H+L) Antibody provides fluorescent detection of goat IgG primary antibodies in ICC/IF, IHC, flow cytometry, and ELISA workflows. It should be used as a secondary reagent for validated goat-IgG assays, not for direct detection or non-goat primary antibodies.
-
Capsaicin: TRPV1 and KDM1A Research Guide
2026-08-13
Capsaicin, also called (E)-Capsaicin, is a dual-mechanism research compound that activates the TRPV1 ion channel and inhibits KDM1A/LSD1. Its strongest mechanistic oncology evidence shows reversible KDM1A inhibition and reduced gastric cancer cell proliferation, migration, invasion, and EMT-associated behavior.
-
DPPH: From Radical Signal to Assay Decision
2026-08-12
DPPH provides a rapid colorimetric readout for in vitro antioxidant screening, but its greatest value lies in how results guide fractionation, orthogonal testing, and natural product decisions. This article connects DPPH chemistry with the multi-assay strategy used for Taihangia rupestris research.
-
Phebestin Targets Plasmodium Aminopeptidases
2026-08-12
The reference study identifies phebestin, a bestatin-related aminopeptidase inhibitor, as a nanomolar antiplasmodial candidate active against both chloroquine-sensitive and chloroquine-resistant Plasmodium falciparum. Its stage-spanning activity, persistent effects after washout, computational interaction with PfM1AAP and PfM17LAP, and supportive mouse data provide a rationale for developing aminopeptidases as malaria drug targets.
-
Capsaicin C6366: Reliable Assay Design
2026-08-11
This scenario-driven guide shows how Capsaicin (SKU C6366) can support controlled cell-viability, proliferation, cytotoxicity, and pain-pathway experiments. It connects concentration selection, solvent handling, mechanism-aware interpretation, and supplier evaluation to published and product-documented data.
-
Remdesivir Beyond the Benchmark: Translational Strategy
2026-08-11
A mechanistic and translational framework for positioning Remdesivir (GS-5734) in coronavirus, filovirus, and emerging RNA-virus research—without confusing demonstrated activity with untested promise.
-
Nirmatrelvir (PF-07321332): 3CLpro Research Guide
2026-08-10
Nirmatrelvir, also called PF-07321332, is an orally bioavailable SARS-CoV-2 3CLpro inhibitor that blocks viral polyprotein processing. Its defined molecular properties and protease-centered mechanism support controlled antiviral therapeutics research, while solubility and assay-boundary considerations remain important.
-
Wnt agonist 1: Workflow for Wnt Signaling Studies
2026-08-09
Wnt agonist 1 (BML-284) provides a practical chemical handle for testing β-catenin–TCF signaling in differentiation, developmental, and cancer models. This workflow connects pathway activation with paired reporter, transcriptional, redox, and phenotype readouts while highlighting controls that prevent overinterpretation.
-
Vancomycin hydrochloride for resistance assays
2026-08-08
Vancomycin hydrochloride provides a mechanism-defined positive control for Gram-positive bacteria inhibition, susceptibility testing, selective media, and resistance-window experiments. This guide connects practical bench workflows with the MIC–MPC framework reported in pneumonia research while clearly separating validated evidence from assay starting conditions.
-
SD 169: Practical p38 MAPK Research Workflows
2026-08-07
SD 169 (indole-5-carboxamide) supports controlled studies of p38α/β signaling in inflammation, type 1 diabetes research, apoptosis, and nerve repair. This workflow-centered guide connects dose preparation, phospho-protein assays, dephosphorylation kinetics, and phenotype-level validation while highlighting practical troubleshooting limits.
-
Calnexin-Dependent Rescue of CFTR Variants: Mechanistic Insi
2026-08-07
Tedman et al. employ deep mutational scanning to systematically profile how the ER chaperone calnexin impacts the expression and pharmacological rescue of over 200 clinical CFTR variants. Their findings reveal domain- and mutation-specific modulation of CFTR folding and corrector efficacy, providing a framework for personalized cystic fibrosis research and therapeutic development.
-
Patient-Derived Gastric Cancer Assembloids Advance Drug Resp
2026-08-06
This study introduces a patient-derived gastric cancer assembloid model that integrates matched tumor organoids and stromal cell subpopulations, offering a more physiologically relevant platform for investigating tumor–stroma interactions and drug resistance. The findings highlight significant differences in gene expression and therapeutic sensitivity compared to traditional organoid monocultures, supporting enhanced personalized drug screening.
-
Epalrestat: Advancing Neuroprotection Beyond Diabetic Resear
2026-08-06
Explore how Epalrestat, a high-purity aldose reductase inhibitor from APExBIO, is redefining translational research strategies in neurodegeneration. This article integrates mechanistic insights—such as KEAP1/Nrf2 pathway activation in Parkinson’s disease models—with practical protocol parameters and strategic guidance, moving the discussion beyond standard product overviews.
-
Strategic Leverage of 5-Aminolevulinic Acid HCl in Heme Path
2026-08-05
Explore how 5-Aminolevulinic acid HCl (5-ALA HCl) uniquely empowers translational researchers to dissect heme biosynthesis, model immune evasion, and advance antineoplastic strategies. Drawing from mechanistic insight and new findings on Salmonella-driven immune modulation, this thought-leadership piece offers actionable guidance and protocol clarity, while distinctly expanding the conversation beyond standard product narratives.